BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 20634933)

  • 21. New trends in the surgical management of soft tissue sarcoma: The role of preoperative biopsy.
    Pavlidis ET; Pavlidis TE
    World J Clin Oncol; 2023 Feb; 14(2):89-98. PubMed ID: 36908679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemotherapy options for patients with advanced soft-tissue sarcoma beyond anthracyclines].
    Italiano A; Toulmonde M; Bui-Nguyen B
    Bull Cancer; 2010 Jun; 97(6):679-86. PubMed ID: 20483708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma.
    Gortzak E; Azzarelli A; Buesa J; Bramwell VH; van Coevorden F; van Geel AN; Ezzat A; Santoro A; Oosterhuis JW; van Glabbeke M; Kirkpatrick A; Verweij J;
    Eur J Cancer; 2001 Jun; 37(9):1096-103. PubMed ID: 11378339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.
    Seddon B; Strauss SJ; Whelan J; Leahy M; Woll PJ; Cowie F; Rothermundt C; Wood Z; Benson C; Ali N; Marples M; Veal GJ; Jamieson D; Küver K; Tirabosco R; Forsyth S; Nash S; Dehbi HM; Beare S
    Lancet Oncol; 2017 Oct; 18(10):1397-1410. PubMed ID: 28882536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.
    Eggermont AM; Schraffordt Koops H; Klausner JM; Kroon BB; Schlag PM; Liénard D; van Geel AN; Hoekstra HJ; Meller I; Nieweg OE; Kettelhack C; Ben-Ari G; Pector JC; Lejeune FJ
    Ann Surg; 1996 Dec; 224(6):756-64; discussion 764-5. PubMed ID: 8968230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.
    Spunt SL; Million L; Chi YY; Anderson J; Tian J; Hibbitts E; Coffin C; McCarville MB; Randall RL; Parham DM; Black JO; Kao SC; Hayes-Jordan A; Wolden S; Laurie F; Speights R; Kawashima E; Skapek SX; Meyer W; Pappo AS; Hawkins DS
    Lancet Oncol; 2020 Jan; 21(1):145-161. PubMed ID: 31786124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of bone and soft-tissue sarcomas registered during the year 2012 at Tata Memorial Hospital, Mumbai, with clinical outcomes.
    Bajpai J; Khanna N; Vora T; Gulia A; Laskar S; Puri A; Sanduptla B; Chinnaswamy G; Nayak P; Juvekar SL; Janu A; Desai S; Ghosh J; Purandare N; Ramadwar M; Rangarajan V; Rekhi B
    Indian J Cancer; 2018; 55(1):37-44. PubMed ID: 30147091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic management strategies for metastatic soft tissue sarcoma.
    Movva S; Verschraegen C
    Drugs; 2011 Nov; 71(16):2115-29. PubMed ID: 22035513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.
    Antman K; Crowley J; Balcerzak SP; Rivkin SE; Weiss GR; Elias A; Natale RB; Cooper RM; Barlogie B; Trump DL
    J Clin Oncol; 1993 Jul; 11(7):1276-85. PubMed ID: 8315425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformal radiotherapy in management of soft tissue sarcoma in adults.
    Le Péchoux C; Llacer C; Sargos P; Moureau-Zabotto L; Ducassou A; Sunyach MP; Biston MC; Thariat J
    Cancer Radiother; 2022; 26(1-2):377-387. PubMed ID: 34961656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The oncological outcomes of isolated limb perfusion and neo-adjuvant radiotherapy in soft tissue sarcoma patients - A nationwide multicenter study.
    van Praag VM; Fiocco M; Bleckman RF; van Houdt WJ; Haas RLM; Verhoef C; Grunhagen DJ; van Ginkel RJ; Bonenkamp JJ; van de Sande MAJ
    Eur J Surg Oncol; 2023 Feb; 49(2):339-344. PubMed ID: 36085118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salvage therapy for soft tissue sarcomas.
    Elias AD
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):76-81. PubMed ID: 8091245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of trabectedin in the treatment of soft tissue sarcoma.
    Nakamura T; Matsumine A; Sudo A
    Ther Clin Risk Manag; 2016; 12():73-9. PubMed ID: 26834480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy in adult soft tissue sarcoma.
    Jain A; Sajeevan KV; Babu KG; Lakshmaiah KC
    Indian J Cancer; 2009; 46(4):274-87. PubMed ID: 19749457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The management of patients with uterine sarcoma: a debated clinical challenge.
    Gadducci A; Cosio S; Romanini A; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline.
    Verma S; Younus J; Stys-Norman D; Haynes AE; Blackstein M
    Curr Oncol; 2007 Aug; 14(4):144-8. PubMed ID: 17710206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Surgical aspects in the multidisciplinary treatment of soft tissue sarcomas].
    Röhrborn A; Röher HD
    Praxis (Bern 1994); 1998 Aug; 87(34):1050-60. PubMed ID: 9757788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limb salvage therapy for soft tissue sarcomas of the foot.
    Selch MT; Kopald KH; Ferreiro GA; Mirra JM; Parker RG; Eilber FR
    Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):41-8. PubMed ID: 2380094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
    Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT;
    Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.